What Is Argireline?
Argireline is the trade name for acetyl hexapeptide-8 (also called acetyl hexapeptide-3, sequence Ac-EEMQRR-NH₂), a synthetic topical cosmetic peptide sold as a “Botox-like” anti-wrinkle ingredient. It is a leave-on skincare ingredient, not an oral supplement or a drug. Its proposed mechanism is to mimic the N-terminal end of SNAP-25 and interfere with SNARE-complex assembly, in principle reducing the neurotransmitter release that drives expression-line muscle contraction. That mechanism is plausible in principle, but the human efficacy evidence for topical application is limited and comes largely from industry or small studies, and skin penetration of the peptide is a recognised limiting factor.
Evidence
The most-cited human signal is an early industry study in which an oil-in-water emulsion containing 10% of the hexapeptide reduced measured wrinkle depth by up to roughly 30% over about 30 days of use in a small group of volunteers 1Reference 1A synthetic hexapeptide (Argireline) with antiwrinkle activity — cosmetic efficacy studyView study →. This is a real, published result and is the origin of most “up to 30% wrinkle reduction” marketing — but it is an early, small, manufacturer-associated study, not an independent randomised trial, so it should be read as suggestive rather than definitive. A recognised practical caveat is that acetyl hexapeptide-8 penetrates skin poorly, which limits how much of any mechanistic effect can actually reach its target under normal topical use. Broader claims of dramatic, injectable-comparable wrinkle removal are common in marketing but I did not find independent, high-quality trial evidence supporting them in this quick pass.
Dosage & Safety
Argireline is a topical cosmetic ingredient, not a dietary supplement or drug, so there is no oral dose; in products it is typically used at low single-digit to ~10% concentrations of the peptide solution, but that is formulation practice rather than a clinically validated dose, and this is not a personal recommendation. As a leave-on cosmetic it is generally regarded as well tolerated on skin, and safety assessments of acetyl hexapeptide-8 for cosmetic use exist; however, formal interaction data, systemic safety and use in pregnancy are not assessed in this pass. Toxicity has not been characterised here beyond the general cosmetic-tolerability picture. Efficacy claims should be treated cautiously given the limited, largely industry-sourced evidence base.
References
- Blanes-Mira, C., et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity — cosmetic efficacy study. International Journal of Cosmetic Science. https://pubmed.ncbi.nlm.nih.gov/18498523/